Skip to main content

People in the News: Mark Dronsfield, Gregory Lucier

Premium

Personalis, provider of genetic sequencing and data interpretation to researchers and clinicians, this week formed a UK subsidiary and appointed Mark Dronsfield as the director of European sales.

In a statement, Personalis said it plans to build services infrastructure and a European commercial team that will address the exome and genome analysis needs of researchers in overseas markets. Dronsfield was previously the head of commercial operations in Europe for RainDance Technologies and has worked in commercial operations for Illumina, Affymetrix, and Life Technologies.


Sanford-Burnham Medical Research Institute's board of trustees has elected Gregory Lucier as its chairman. Lucier is chairman and CEO of Life Technologies and will take up his post as Sanford-Burnham's board chairman starting September 18.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.